Related Experiment Videos
[Prognostic factors in resected stomach carcinoma]
D Oertli1, U Herzog, P Tondelli
1Allgemeinchirurgische Klinik, St. Claraspital Basel.
Schweizerische Medizinische Wochenschrift
|June 4, 1994
Summary
This study identified key prognostic factors for gastric adenocarcinoma survival, including tumor stage and lymph node involvement. These findings can help estimate individual patient survival probabilities and guide future adjuvant treatment decisions.
Area of Science:
- Oncology
- Surgical Oncology
- Gastroenterology
Context:
- Gastric adenocarcinoma presents a significant global health challenge.
- Treatment strategies often involve surgical resection and lymphadenectomy.
- Accurate prognostic indicators are crucial for patient management.
Purpose:
- To identify significant prognostic factors for survival in gastric adenocarcinoma patients.
- To evaluate the impact of tumor stage, lymph node status, and other clinical parameters on patient outcomes.
- To assess the prognostic value of Borrmann and Laurén classifications, and TNM staging.
Summary:
- A retrospective analysis of 232 gastric adenocarcinoma patients treated between 1982-1991.
- Identified tumor stage (TNM), N-stage, lymph node metastasis percentage, Borrmann criteria, T-stage, lymph node count, tumor diameter, serosal involvement, peritoneal/hepatic metastases, and age as significant prognostic factors.
- Grading, Laurén classification, and tumor location were not significant prognostic indicators in this cohort.
Impact:
- The study provides a robust framework for estimating individual patient survival probabilities.
- Findings can inform clinical decision-making regarding adjuvant therapy for gastric cancer.
- Highlights the importance of comprehensive staging and lymph node assessment in gastric cancer prognosis.